Zusammenfassung
Der Echinococcus alveolaris (multilocularis) wächst beim Menschen wie ein maligner Tumor expansiv, infiltrativ destruierend und metastasierend. Die einzige Heilungsmöglichkeit besteht in einer kompletten Resektion. Weil die Echinokokkose schleichend beginnt und die Symptome sehr uncharakteristisch sind, wird die Diagnose oft erst zu einem Zeitpunkt gestellt, wenn die Echinokokkose nicht mehr kurativ resezierbar ist. Tierexperimentelle Untersuchungen [1, 3] und zahlreiche klinische Beobachtungen [7], z. T. in Form prospektiver Studien [5, 6] haben gezeigt, daß durch Mebendazol, ein Benzimidazolderivat, das weitere Wachstum der alveolären Echinokokkose verhindert, die Metacestoden aber nicht abgetötet werden können.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Literatur
Campbell WC, Blair LS (1974) Treatment of the cystic stage of Taenia crassiceps and Echinococcus multilocu1aris in laboratory animals. J ParasitoI 60: 1053–1054
Dawson M et al. (1982) The pharmacokinetics and bioavai1ability of mebendazole in man: A pilot study using 3H-mebendazole. Br J Clin PharmacoI 14: 453–455
Eckert J, Pohlenz J (1976) Zur Wirkung von Mebendazol auf Metazestoden von Mesocestoides corti und Echinococcus multilocularis. Tropenmed Parasitol 27: 247–262
Junge U, Mohr W (1983) Mebendazol-Hepatitis. Z Gastroenterol 21: 736–738
Kern P (1983) Human echinococcosis: follow-up of 23 patients treated with mebendazole. Infection 11: 17–24
Müller E et al. (1982) Treatment of human echinococcosis with mebendazole: preliminary observations in 28 patients. Hepatogastroentero1 29: 236–239
Schantz PM et al. (1982) Chemotherapy for larval echinococcosis in animals and humans: report of a workshop. Z Parasitenkd 67: 5–26
Seitz R et al. (1983) Hepatozelluläre Arzneimittelreaktion unter Mebendazoltherapie bei Echinococcus cysticus. Z Gastroenterol 21: 324–329
Arndorfer RC, Steff JJ, Dodds WJ, Linehan JH, Hogan WJ (1977) Improved infusion system for intraluminal oesophageal manometry. Gastroenterology 24: 7–23
Bar-Meir S, Greenen JE, Hogan WJ (1979) Biliary and pancreatic duct pressures measured by ERCP manometry in patients with suspected papillary stenosis. Dig Dis Sci 24: 209–213
Carr-Locke DL, Gregg JA (1981) Endoscopic manometry of pancreatic and biliary sphincter zones in man: basal results in healthy and volunteers. Dig Dis Sci 26: 7–15
Cotton PB (1972) Cannulation of the papilla of Vater by endoscopy and retrograde cholangiopancreatography (ERCP). Gut 13: 1014–1017
Csendes A, Kruse A, Funch-Jensen P (1979) Pressure measurements in the biliary tract and pancreatic duct system in controls and in patients with gallstones, previous cholecystectomy or common bile duct stones. Gastroenterology 77: 1203–1210
Gennen JE, Hogan WJ, Dodds WJ, Stewart ET, Arndorfer RC (1980) Intraluminal pressure recording from the human sphincter of Oddi. Gastroenterology 78: 317–324
Hand BH (1973) Anatomy and function of the extrahepatic biliary system. Clin Gastroenterol 2: 3–29
Hopton DS, Torrance HB (1967) Action of various drugs on the human common bile duct. Gut 8: 296–300
Kroesen G, Bodner E, Russe W (1978) Beeinflussung der intraoperativen Cholangiomanometrie durch Anästhesiemethoden. Anaesthesist 27: 21–24
Ono K, Watanabe N, Suzuki K, Tsuchida H, Sugiyama Y, Abo M (1968) Bile flow mechanisms in man. Arch Surg 96: 869–874
Persson OA, Ekman M (1972) Effect of morphine CCK and sympathicomimetics on the sphincter of Oddi and intramural pressure on cat duodenum. Scand J Gastroenterol 7: 345–349
Staritz M, Ewe K, Meyer zum Büschenfelde K-H (1983) Endoskopische Papillen- and Gallenwegsmanometrie bei Patienten mit Cholezystolithiasis. Verh Dtsch Ges Inn Med 89: 837–840
Debongnie JC, Pauls C, Fievez M, Wibin E (1981) Prospective evaluation of the diagnostic accuracy of liver. Ultrasonography Gut 22: 130–135
Foster KJ, Dewbury KG, Griffith AH, Wright R (1980) Br J Radiol 53: 440–442
Geissler M, Lorenz A, Zabel HJ, Lorenz WJ, Schlaps D, Zuna I (1982) A computerizid echographic data aquisitation and evaluation system for tissue characterization. Proc World Congr Med Phys Biomed Ing, Hamburg
Lachenbruch PA (1975) Discriminant analyses. Hafner Press, Macmillan Publ Co
Rettenmaier G (1977) Lebersonographie. Thieme Copythek. Thieme, Stuttgart
Carulli N, Manenti F, Gallo M, Salvioli GF (1971) Alcohol-drug interaction in man: alcohol and tolbutamide. Eur J Clin Invest 1: 421–424
Hoensch H, Hartmann F, Schomerus H, Bieck P, Dölle W (1979) Monooxygenase enzyme activity in alcoholics with varying degree of liver damage. Gut 20: 666–672
Hoensch H (1981) Fremdstoff-abbauendes Enzym-System der menschlichen Leber. Fortschr Med 99: 784–787
Hoensch H (1984) Enzyminduktion der Leber durch chronischen Alkoholismus als Risikofaktor der Hepatotoxizität. Z Gastroenterol 22: 1–8
Iber FL (1977) Drug metabolism in heavy consumers of ethyl alcohol. Clin Pharmacol Exp Ther 22: 735–742
Lieber CS (1973) Hepatic and metabolic effects of alcohol. Gastroenterology 65: 821–846
Misra PS, Le Fevre A, Ischi H, Rubin E, Lieber C (1971) Increase in ethanol, meprobamate and pentobarbital metabolism after chronic ethanol administration in man and in rats. Am J Med 51: 346–352
Neuvonen PJ, Penttilä O, Roos O, Tirkonen J (1976) Effect of long term alcohol consumption on the half live of tetracycline and doxycycline in man. Int J Clin Pharmacol Biopharm 14: 303–307
Ohnhaus EE, Gerber-Taras E, Park BK (1983) Enzyme-inducing drug combinations and their effects on liver microsomal enzyme activity in man. Eur J Clin Pharmacol 24: 247–250
Monna T (1982) Malotilate Symposium, World Congress of Gastroenterology, Stockholm 1982, Abstracts
Katoh M, Kitada M, Satoh T, Kitagawa H, Sugimoto T, Kasai T (1981) Further studies on the in vivo effect of Diisopropyl 1,3-dithiol-2-ylidenemalonate (NKK 105) on the liver microsomal drug oxidation system in rats. Biochem Pharmacol 30: 2759–2765
Voss B, Rauterberg J, Pott G et al. (1982) Nonparenchymal cells cultivated from explants of fibrotic liver resemble endothelial and smooth muscle cells from blood vessel walls. Hepatology 2: 19–28
Rohde H, Hahn E, Timpl R (1978) Radioimmunoassay for amino terminal procollagen peptide in liver diseases. Fresenius Z Analyt Chem 290: 151
Ackermann W, Pott G, Voss B, Müller K-M, Gerlach U (1981) Serum concentration of procollagen-III-peptide in comparison with the serum activity of N-acetyl-ß-glucosaminidase for diagnosis of the activity of liver fibrosis in patients with chronic active liver disease. Clin Chim Acta 112: 365–369
Bührer M, Le Cotonnec JY, Wermeille M, Bircher J (1983) Auf dem Weg zu einer antifibrotischen Therapie der Leberzirrhose. Pilotstudien mit Malotilat. Jahrestagung der Schweizerischen Gesellschaft für Gastroenterologie 1983. Abstraktband
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Junge, U. et al. (1984). Hepatologie II. In: 90. Kongreß. Verhandlungen der Deutschen Gesellschaft für Innere Medizin, vol 90. J.F. Bergmann-Verlag, Munich. https://doi.org/10.1007/978-3-642-85457-6_30
Download citation
DOI: https://doi.org/10.1007/978-3-642-85457-6_30
Publisher Name: J.F. Bergmann-Verlag, Munich
Print ISBN: 978-3-8070-0342-9
Online ISBN: 978-3-642-85457-6
eBook Packages: Springer Book Archive